| Code | CSB-RA054260A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:2000 |
| IHC | 1:50-1:200 |
Neurofilament medium polypeptide (NEFM) serves as a critical structural component of the neuronal cytoskeleton, where it contributes to axonal caliber, stability, and the maintenance of proper nerve conduction velocity. As one of three neurofilament subunits, NEFM has emerged as a valuable marker in neuroscience research, with particular relevance to studies of neurodegeneration, axonal injury, and nervous system development.
This recombinant monoclonal antibody, clone 6F12, offers the reproducibility and consistency that demanding neurological research requires. Because the antibody sequence is defined and produced recombinantly in rabbit host cells, you can expect reliable performance across experiments and over time, eliminating the lot-to-lot variability that can complicate long-term studies or multi-site collaborations.
Validation testing demonstrates robust performance across multiple applications. In western blot analysis, the antibody detects NEFM in both SH-SY5Y neuroblastoma and HEK293T cell lysates at dilutions of 1:500 to 1:2000. The observed band at approximately 160 kDa exceeds the predicted molecular weight of 102 kDa, which reflects the extensive phosphorylation characteristic of neurofilament proteins in their native state. For tissue-based studies, immunohistochemical staining has been validated in paraffin-embedded human glioma tissue sections at dilutions of 1:50 to 1:200, revealing clear target localization using standard antigen retrieval protocols.
Whether you are investigating neurodegenerative disease mechanisms, characterizing neural differentiation, or examining nervous system pathology, this antibody provides a dependable tool for detecting NEFM in human samples across both cell-based and tissue applications.
There are currently no reviews for this product.